A Gene Transfer Therapy Study to Evaluate the Safety and Efficacy of Delandistrogene Moxeparvovec (SRP-9001) Following Imlifidase Infusion in Participants With Duchenne Muscular Dystrophy (DMD) Determined to Have Pre-existing Antibodies to Recombinant Adeno-Associated Virus Serotype (rAAVrh74)
Clinical trial NCT06241950 · TERMINATED
Trial details
- NCT number
- NCT06241950
- Sponsor
- Sarepta Therapeutics, Inc.
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-01-29
- Primary completion
- 2025-10-10
- Enrollment
- 5
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.